High-Throughput Chemical Screening and Structure-Based Models to Predict hERG Inhibition

被引:12
|
作者
Krishna, Shagun [1 ]
Borrel, Alexandre [2 ]
Huang, Ruili [3 ]
Zhao, Jinghua [3 ]
Xia, Menghang [3 ]
Kleinstreuer, Nicole [1 ]
机构
[1] NIEHS, Div Natl Toxicol Program, Res Triangle Pk, NC 27560 USA
[2] Silent Spring Inst, Newton, MA 02460 USA
[3] Natl Ctr Adv Translat Sci NCATS, Div Preclin Innovat, Bethesda, MD 20892 USA
来源
BIOLOGY-BASEL | 2022年 / 11卷 / 02期
基金
美国国家卫生研究院;
关键词
cardiovascular; hERG; Tox21 high-throughput screening; environmental chemicals; in silico modeling; QSAR models; POTASSIUM CHANNEL BLOCKAGE; CARDIAC-ARRHYTHMIA; DRUGS; DISINFECTANTS; PROLONGATION; TERFENADINE; MECHANISM; AFFINITY; INTERVAL; BROMIDE;
D O I
10.3390/biology11020209
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple Summary Cardiovascular disease is the leading cause of death for people of most ethnicities in the United States. The human ether-a-go-go-related gene (hERG) potassium channel plays a pivotal role in cardiac rhythm regulation, and cardiotoxicity associated with hERG inhibition by drug molecules and environmental chemicals is a major public health concern. An evaluation of the effect of environmental chemicals on hERG channel function can help inform the potential public health risks of these compounds. To assess the cardiotoxic effect of diverse drugs and environmental compounds, the Tox21 federal research program has screened a collection of 9667 chemicals for inhibitory activity against the hERG channel. A set of molecular descriptors covering physicochemical and structural properties of chemicals, self-organizing maps, and hierarchical clustering were applied to characterize the chemicals inhibiting hERG. Machine learning approaches were applied to build robust statistical models that can predict the probability of any new chemical to cause cardiotoxicity via this mechanism. Chemical inhibition of the human ether-a -go-go-related gene (hERG) potassium channel leads to a prolonged QT interval that can contribute to severe cardiotoxicity. The adverse effects of hERG inhibition are one of the principal causes of drug attrition in clinical and pre-clinical development. Preliminary studies have demonstrated that a wide range of environmental chemicals and toxicants may also inhibit the hERG channel and contribute to the pathophysiology of cardiovascular (CV) diseases. As part of the US federal Tox21 program, the National Center for Advancing Translational Science (NCATS) applied a quantitative high throughput screening (qHTS) approach to screen the Tox21 library of 10,000 compounds (~7871 unique chemicals) at 14 concentrations in triplicate to identify chemicals perturbing hERG activity in the U2OS cell line thallium flux assay platform. The qHTS cell-based thallium influx assay provided a robust and reliable dataset to evaluate the ability of thousands of drugs and environmental chemicals to inhibit hERG channel protein, and the use of chemical structure-based clustering and chemotype enrichment analysis facilitated the identification of molecular features that are likely responsible for the observed hERG activity. We employed several machine-learning approaches to develop QSAR prediction models for the assessment of hERG liabilities for drug-like and environmental chemicals. The training set was compiled by integrating hERG bioactivity data from the ChEMBL database with the Tox21 qHTS thallium flux assay data. The best results were obtained with the random forest method (~92.6% balanced accuracy). The data and scripts used to generate hERG prediction models are provided in an open-access format as key in vitro and in silico tools that can be applied in a translational toxicology pipeline for drug development and environmental chemical screening.
引用
收藏
页数:26
相关论文
共 50 条
  • [31] Structure-Based Optimization of Potent, Selective, and Orally Bioavailable CDK8 Inhibitors Discovered by High-Throughput Screening
    Czodrowski, Paul
    Mallinger, Aurelie
    Wienke, Dirk
    Esdar, Christina
    Poeschke, Oliver
    Busch, Michael
    Rohdich, Felix
    Eccles, Suzanne A.
    Ortiz-Ruiz, Maria-Jesus
    Schneider, Richard
    Raynaud, Florence I.
    Clarke, Paul A.
    Musil, Djordje
    Schwarz, Daniel
    Dale, Trevor
    Urbahns, Klaus
    Blagg, Julian
    Schiemann, Kai
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (20) : 9337 - 9349
  • [32] A novel structure-based virtual screening model for the hERG channel blockers
    Du, Lupei
    Li, Minyong
    You, Qidong
    Xia, Lin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 355 (04) : 889 - 894
  • [33] High-Throughput Screening to Identify Chemical Cardiotoxic Potential
    Krishna, Shagun
    Berridge, Brian
    Kleinstreuer, Nicole
    CHEMICAL RESEARCH IN TOXICOLOGY, 2021, 34 (02) : 566 - 583
  • [34] High-throughput screening assays for the identification of chemical probes
    Inglese, James
    Johnson, Ronald L.
    Simeonov, Anton
    Xia, Menghang
    Zheng, Wei
    Austin, Christopher P.
    Auld, Douglas S.
    NATURE CHEMICAL BIOLOGY, 2007, 3 (08) : 466 - 479
  • [35] High-throughput screening assays for the identification of chemical probes
    James Inglese
    Ronald L Johnson
    Anton Simeonov
    Menghang Xia
    Wei Zheng
    Christopher P Austin
    Douglas S Auld
    Nature Chemical Biology, 2007, 3 : 466 - 479
  • [37] High-throughput screening
    Aris Persidis
    Nature Biotechnology, 1998, 16 : 488 - 489
  • [38] High-throughput screening
    Lloyd, A
    DRUG DISCOVERY TODAY, 1998, 3 (12) : 566 - 566
  • [39] High-throughput screening
    Persidis, A
    NATURE BIOTECHNOLOGY, 1998, 16 (05) : 488 - 489
  • [40] High-throughput screening
    Wallace, RW
    DRUG DISCOVERY TODAY, 1998, 3 (02) : 92 - 93